Citation: | WANG Hang, XU Qixia, LI Xiaoqing, WANG Yueyue. Analysis of long-term prognostic factors in patients with acute pulmonary embolism[J]. Chinese Journal of General Practice, 2023, 21(9): 1466-1469. doi: 10.16766/j.cnki.issn.1674-4152.003147 |
[1] |
KONSTANTINIDES S V, MEYER G, BECATTINI C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society[J]. Eur Heart J, 2020, 41(4): 543-603. doi: 10.1093/eurheartj/ehz405
|
[2] |
ZHAI Z, WANG D, LEI J, et al. Trends in risk stratification, in-hospital management and mortality of patients with acute pulmonary embolism: an analysis from the China pulmonary thromboembolism registry study[J]. Eur Respir J, 2021, 58(4): 1-11.
|
[3] |
李小晴, 许启霞, 庞颖颖. 肺血栓栓塞症预后因素分析[J]. 中华全科医学, 2017, 15(6): 1022-1026.
LI X Q; XU Q X. Analysis of prognostic factors in patients with pulmonary thromboembolism[J]. Chinese Journal of General Practice, 2017, 15(6): 1022-1026.
|
[4] |
中华医学会呼吸病学分会肺栓塞与肺血管病学组, 中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会, 全国肺栓塞与肺血管病防治协作组. 肺血栓栓塞症诊治与预防指南[J]. 中华医学杂志, 2018, 98(14): 1060-1087. doi: 10.3760/cma.j.issn.0376-2491.2018.14.007
Pulmonary embolism and pulmonary vascular Disease Group, Chinese Medical Association Respiratory Branch, Pulmonary embolism and pulmonary Vascular Disease Working Committee, Chinese Medical Doctor Association Respiratory Physician Branch, National pulmonary embolism and pulmonary vascular disease Prevention and Treatment Collaboration group. Guidelines for diagnosis, treatment and prevention of pulmonary thromboembolism[J]. Chinese Medical Journal, 2018, 98(14): 1060-1087. doi: 10.3760/cma.j.issn.0376-2491.2018.14.007
|
[5] |
张拓北. 肺癌患者并发肺栓塞的影响因素及预后[J]. 中国卫生工程学, 2022, 21(1): 75-77. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWX202201023.htm
ZHANG T B. Influencing factors and prognosis of pulmonary embolism in patients with lung cancer[J]. Chin J Public Health Eng, 2022, 21(1): 75-77. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWX202201023.htm
|
[6] |
JACK L, LOCKARD C. Thrombocytosis assiciated with malignant[J]. Arch Intern Med, 1964, 23(9): 497-500.
|
[7] |
ALBERTSEN I E, NIELSEN P B, SOGAARD M, et al. Risk of recurrent venous thromboembolism: a Danish nationwide cohort study[J]. Am J Med, 2018, 131(9): 1067-1074. doi: 10.1016/j.amjmed.2018.04.042
|
[8] |
张丽, 万毅新, 王虹. 肺栓塞患者合并肿瘤与非肿瘤的危险因素分析[J]. 甘肃医药, 2022, 41(10): 881-884. https://www.cnki.com.cn/Article/CJFDTOTAL-GSYY202210006.htm
ZHANG L, WAN Y X, WANG H. Analysis of risk factors for pulmonary embolism patients with tumor and non-tumor[J]. Gansu Med J, 2022, 41(10): 881-884. https://www.cnki.com.cn/Article/CJFDTOTAL-GSYY202210006.htm
|
[9] |
付萌, 庞桂芬. 慢性阻塞性肺疾病合并肺栓塞临床诊治进展[J]. 临床医药文献电子杂志, 2018, 5(87): 186-188. https://www.cnki.com.cn/Article/CJFDTOTAL-LCWX201887164.htm
FU M, PANG G F. Advances in clinical diagnosis and treatment of chronic obstructive pulmonary disease complicated with pulmonary embolism[J]. Journal of Clinical Medicine Literature, 2018, 5(87): 186-188. https://www.cnki.com.cn/Article/CJFDTOTAL-LCWX201887164.htm
|
[10] |
朱晓敏, 罗健, 李苗苗, 等. 慢性阻塞性肺疾病患者并发静脉血栓栓塞症危险因素的Meta分析[J]. 中华护理杂志, 2019, 54(5): 746-752. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHHL201905031.htm
ZHU X M, LUO J, LI M M, et al. Meta-analysis of risk factors for venous thromboembolism in patients with chronic obstructive pulmonary disease[J]. Chin J Nurs, 2019, 54(5): 746-752. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHHL201905031.htm
|
[11] |
KELLER K, BEULE J, COLDEWEY M, et al. The risk factor age in normotensive patients with pulmonary embolism: effectiveness of age in predicting submassive pulmonary embolism, cardiac injury, right ventricular dysfunction and elevated systolic pulmonary artery pressure in normotensive pulmonary embolism patients[J]. Exp Gerontol, 2015, 69: 116-121. doi: 10.1016/j.exger.2015.05.007
|
[12] |
王小强, 王艳, 张艳东, 等. 炎症因子检测对慢性阻塞性肺疾病急性加重期的诊断价值[J]. 山西医药杂志, 2017, 46(7): 802-804. https://www.cnki.com.cn/Article/CJFDTOTAL-SXYY201707029.htm
WANG X Q, WANG Y, ZHANG Y D, et al. Diagnostic value of inflammatory factor detection in acute exacerbation of chronic obstructive pulmonary disease[J]. Shanxi Med J, 2017, 46(7): 802-804. https://www.cnki.com.cn/Article/CJFDTOTAL-SXYY201707029.htm
|
[13] |
LITUS E A, PERMYAKOV S E, UVERSKY V N, et al. Intrinsically disordered regions in serum albumin: what are they for?[J]. Cell Biochem Biophys, 2018, 76(1-2): 39-57.
|
[14] |
NICHOLSON J P, WOLMARANS M R, PARK G R. The role of albumin in critical illness[J]. Br J Anaesth, 2000, 85(4): 599-610.
|
[15] |
庞颖颖, 刘海涛. 生物标志物与急性肺栓塞危险分层及预后的关联性研究[J]. 中华全科医学, 2022, 20(2): 199-201, 281. doi: 10.16766/j.cnki.issn.1674-4152.002311
PANG Y Y, LIU H T. Association of biomarkers with risk stratification and prognosis of acute pulmonary embolism[J]. Chinese Journal of General Practice, 2022, 20(2): 199-201, 281. doi: 10.16766/j.cnki.issn.1674-4152.002311
|
[16] |
KUNUTSOR S K, SEIDU S, KATECHIA D T, et al. Inverse association between serum albumin and future risk of venous thromboembolism: interrelationship with high sensitivity C-reactive protein[J]. Ann Med, 2018, 50(3): 240-248.
|